Biogen | Attività Correnti



Current Assets Cambiamento Data
AbbVie USD 25.58B 2.2B 2024-12
Acadia Pharmaceuticals USD 938.32M 150.03M 2024-12
ALKERMES USD 1.42B 167.74M 2024-12
Amgen USD 29.03B 2.26B 2024-12
Bayer EUR 34.44B 1.31B 2024-12
Biogen USD 7.46B 626.3M 2024-12
BioMarin Pharmaceutical USD 3.23B 175.84M 2024-12
Bristol-Myers Squibb USD 30.78B 1B 2025-03
Eli Lilly USD 41.26B 8.52B 2025-03
Gilead Sciences USD 19.17B 4.39B 2024-12
Incyte USD 3.23B 7.24M 2025-03
Merck USD 38.78B 1.58B 2024-12
Moderna USD 6.77B 1.33B 2025-03
Neurocrine Biosciences USD 1.72B 151.9M 2024-12
Novartis USD 29.7B 1.56B 2024-12
Pfizer USD 50.36B 7.14B 2024-12
PTC Therapeutics USD 1.37B 83.98M 2024-12
Regeneron Pharmaceuticals USD 17.57B 9.64B 2025-03
Sanofi 44.02B 1.43B 2025-03
Sanofi 42.59B 12.51B 2024-12
Sarepta Therapeutics USD 3.07B 388.09M 2024-12
Teva Pharmaceutical Industries USD 12.55B 238M 2024-12
Ultragenyx Pharmaceutical USD 817.12M 17.52M 2024-12
United Therapeutics USD 3.94B 65.9M 2025-03
Vertex Pharmaceuticals USD 9.6B 207.7M 2024-12



Biogen Attività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.